Table 4.
Content changes of marker compounds in the compatibility of DHI and infusion solutions.
| Infusion solutions | Compatible time | Content changes of marker compounds(%) |
||||||
|---|---|---|---|---|---|---|---|---|
| SaA | SaB | RA | DSS | PA | CA | SG | ||
| DHI-GS | – | – | – | – | – | – | – | – |
| DHI-NS | 6 h | – | – | – | – | 16.1 | – | – |
| DHI-GNS | 4 h | – | – | – | 18.4 | 10.3 | – | – |
| 6 h | – | – | – | 21.4 | 22.6 | 16.4 | – | |
| DHI-FI | 4 h | – | – | – | 5.3 | 15.4 | – | – |
| 6 h | – | – | – | 7.2 | 19.2 | 9.2 | – | |
| DHI-XI | 4 h | – | – | – | 24.8 | 24.8 | – | – |
| 6 h | – | 5.7 | 6.2 | 26.1 | 26.9 | – | – | |
| DHI-DGI | 2 h | – | – | – | 6.0 | 5.4 | – | – |
| 4 h | – | – | – | 12.9 | 10.3 | 6.7 | 6.2 | |
| 6 h | – | 6.4 | 7.3 | 21.4 | 22.6 | 15.1 | 9.0 | |
– Indicated no significant change. The information of time points with compatible stability (content changes of marker compounds were less than 5%) were not shown in this table.